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Abstract
Background: To investigate patterns of failure and survival rates of elective irradiation of upper neck in N0
nasopharyngeal carcinoma patients.
Methods: From February 1996 to November 2002, 97 patients without cervical lymph node involvement were
admitted for radiotherapy alone. Before treatment, each patient underwent enhanced CT of nasopharynx and neck.
All patients received radiotherapy to the nasopharynx, skull base, and upper neck drainage areas (including levels II,
III, and VA). The upper neck was irradiated to a total dose of 50-56 Gy/25-28 fractions/5-5.6 weeks. For the primary
tumor, 22 patients used conventional fractionation for a total dose of 70 Gy/35 fractions/7 weeks, and 75 patients
used an accelerated hyperfractionationated schedule for a total dose of 78 Gy/60 fractions/6 weeks.
Results: The median follow-up of these 97 patients was 7.75 years. 10 patients had recurrences in the
nasopharynx, 8 had distant metastasis, and 5 had recurrences in the cervical lymph nodes. Among the cervical
lymph node failures, the areas of recurrence were in the II drainage areas in 4 patients who had neck dissections
afterwards, and in IA drainage areas in 1 patient who also had recurrence in the nasopharynx. The causes of death
were recurrence in the nasopharynx for 8 patients, 1 of these also had recurrence in the neck, distant metastases
in 8 patients, and non-neoplastic diseases in 3 patients.
Conclusions: The causes of failure of N0 patients with nasopharyngeal carcinoma after radiotherapy alone to the
nasopharynx and upper neck were nasopharyngeal recurrence, distant metastasis, and cervical recurrence in order
of frequency. Elective irradiation of upper neck (II, III, VA) is advised for stage N0 patients diagnosed by enhanced
CT of neck. Cervical recurrence alone is rare, which did not greatly affect the long-term survival after salvage neck
dissection.
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Introduction
Cervical lymph node metastasis is common in nasophar-
yngeal carcinoma (NPC). The 5-year survival rate was
50-70% after radiotherapy alone and the major cause of
treatment failure is distant metastasis, followed by naso-
pharyngeal and neck recurrence [1-3]. Improving the
efficacy and reducing the side effects of radiotherapy
have been the two goals of all radiation oncologists. As
radiation can cause neck fibrosis [3,4], methods of
decreasing neck radiation reaction were studied. Redu-
cing the volume irradiated can markedly improve the
quality of life. 18.7-26.5% of patients with nasopharyn-
geal carcinoma at initial presentation were stage N0
[5-7]. Radiation is given to N0 patients either electively
to the upper neck (II, III, VA) lymph node drainage area
only, or to the whole neck (II, III, VA, IV, VB) [8-10].
This study is to analyze the pattern of relapse and survi-
val for stage N0 nasopharyngeal carcinoma after elective
irradiation to the upper neck only. * Correspondence: zhenzhangsh@yahoo.cn
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Patients eligible for this study were all treated at the
Cancer Hospital of Fudan University. The eligibility cri-
teria were: above 18 years old but not more than 70 years
old, biopsy proven pathologically as World Health Organi-
zation (WHO) type III NPC, stage N0 disease according to
AJCC 2002 staging system, KPS≥70, and no evidence of
distant metastasis.
Initial evaluation included: medical history and physical
examination, liver and renal functions, chest x-ray, liver
ultra-sonography, contrast-enhanced computed tomogra-
phy (CT) of the nasopharynx and neck, as well as naso-
pharyngoscopy. Additional investigations were performed
only for those with suspicious findings. Dental extraction
if deemed necessary was performed before radiation ther-
apy. The study procedures were in accordance with the
ethical standards of the Committee on Human Experi-
mentation of Cancer Center, Fudan University. All
patients signed an informed consent before entry into the
study.
Patients were immobilized using a thermoplastic mask
while receiving radiotherapy and two-dimensional treat-
ment planning system (TPS) was done. The upper neck
nodal regions were included in the large facio-cervical
fields that were used up to 40 Gy to the primary tumor.
Then the primary fields were reduced to smaller pre-auri-
cular fields. To supplement the dose to the upper neck,
either a frontal field with Cobalt 60 with middle shielding
or direct fields with 9 MeV electrons were used. The
upper neck (including levels II, III, and VA) was irradiated
to a total dose of 50-56 Gy/25-28 fractions/5-5.6 weeks.
Elective Irradiation was not given to the lower neck (IV,
VB). For the primary tumor, 22 patients used conventional
fractionation for a total dose of 70 Gy/35 fractions/7
weeks, and 75 patients used an accelerated hyperfractiona-
tionated schedule for a total dose of 78 Gy/60 fractions/6
weeks, of which 48 Gy was given in 40 fractions using 2
fractions per day, 1.2 Gy/fraction, with an interval of
≥ 6 h, 5 days per week, followed by 30 Gy in 20 fractions
using 2 fractions per day, 1.5 Gy/fraction, 5 days per week.
After completion of radiotherapy, patients were fol-
lowed up every 3 months during the first 2 years, and
every 6 months thereafter. In addition to routine
checkup, CT scans of nasopharynx and upper neck were
performed every year. Post-irradiation toxicities were
observed and recorded using the Radiation Therapy
Oncology Group (RTOG) criteria.
Local control, cervical lymph node control, distant
metastases and survival rates were calculated from the
start of treatment to the dates of recurrence, metastases,
and death. The Kaplan-Meier method was used to cal-
culate local control, distant metastases and survival
rates.
Results
This trial included 97 consecutive patients with stage
N0, who had pathologically confirmed WHO type III
NPC, between February 1996 and November 2002.
Among them, there were 70 males and 27 females, and
their median age was 50 years (range: 20-70 years). The
2002 American Joint Committee on cancer (AJCC) sta-
ging system was used for the classification of the pri-
mary lesion which was as follows: T1: 20 patients; T2:
50; T3: 9 and T4: 18. Characteristics of the 97 patients
are listed in Table 1. The median follow-up time was
7.75 years (range, 10 months-11.1 years).
Five patients developed regional relapse: 2 patients in
T1, 2 in T2, and 1 in T4. The 5-year cervical lymph
node control rate was 94.3% (Figure 1). Four patients
had recurrence in II drainage areas, who underwent sal-
vage neck dissection and achieved long-term survival.
One patient failed in IA drainage areas who also had
nasopharyngeal recurrence. According to RTOG criteria,
the neck fibrosis of all patients was grade 0-1 after
radiotherapy.
Ten patients developed local recurrence of the pri-
mary lesion: 1 in T1, 4 in T2, 2 in T3, and 3 patients in
T4. The 5-year local control rate was 91.4%. For T1-2,
T3-4, the 5-year local control rates were 95.6% and
80.8%, respectively (P =0 . 0 6 3 )( F i g u r e2 ) .T h e s et e n
patients were re-irradiated, and two of them achieved
long-term survival.
A total of 8 patients developed distant metastases: 2 in
T1, 3 in T2, and 3 patients in T4. The sites of distant
metastases were bone (2 patients), lung (2 patients), and
liver (4 patients), The 5-year distant metastasis-free rate
was 92.5%.
Table 1 Patient characteristics
Number of patients %
Age, year
Range 20-70
≥ 60 23 23.7
< 60 74 76.3
Gender
Male 70 72.2
Female 27 27.8
Histology
WHO Type I 0 0
WHO Type II 0 0
WHO Type III 97 100
Stage
T1 20 20.6
T2 50 51.5
T3 9 9.3
T4 18 18.6
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The 5-year overall survival rate was 82.3%. For T1-2,
T3-4, the 5-year overall survival rate were 87.1%, 69.2%,
respectively (P = 0.009) (Figure 3). Causes of death for
19 patients were as follows: 7 patients died of nasophar-
yngeal recurrence, 1 patient died of both nasopharyngeal
and neck recurrence, 8 patients died of distant metasta-
sis, and 3 patients died of non-neoplastic diseases.
Discussion
All stage N0 patients with nasopharyngeal carcinoma in
our study who were treated by radiotherapy alone did
not receive prophylactic irradiation of lower neck lymph
node drainage area, but the radiation fields covered the
upper neck lymph drainage region including levels II,
III, VA and the primary disease. The regional cervical
control rate was 94.3%. Recurrence in four patients
appeared in II drainage region and one patient failed in
IA region. No recurrence in IV region or supraclavicular
lymph nodes was observed. Therefore, it is suggested
that irradiation to the upper neck only is adequate. The
radiation fields in our patients were similar to patients
of Dr. Gao, but our patients were only given radiother-
apy. Chemotherapy was not protocolized in all patients
of Dr. Gao and was used at the discretion of the attend-
ing physician in individual cases, including neoadjuvant
chemotherapy using cisplatin and fluorouracil, concur-
rent and adjuvant cisplatin-based chemotherapy [11].
We think that the result of radiotherapy alone would be
more persuasive in that it avoided the effect of com-
bined chemotherapy as a confound variable.
Neck lymph node metastasis rate of nasopharyngeal
carcinoma was about 70-80%. Therefore, some researchers
proposed irradiation of the whole neck regardless of N sta-
ging. Li reported the results of 2523 patients in 1991: if the
whole neck was irradiated, cervical lymph nodes recur-
rence rates in N+, N0 patients were 12% and 11%, respec-
tively. For those N0 patients who did not receive elective
node irradiation, the cervical lymph nodes recurrence rate
was 38%. And the overall survival rates were 86.6% and
58.8% for patients who have and have not received elective
node irradiation, respectively [12-14]. Although most
researchers including Radiation Therapy Oncology Group
(RTOG) require routine whole neck irradiation regardless
of the status of nodal metastasis [15,16], other researchers
recommended that elective radiation of only the upper
neck (level II, III, and VA) is sufficient for N0 patients
[13-15]. Chen studied 432 N0 patients without elective
irradiation to the lower neck [13], of whom 17 patients
had recurrences in the cervical lymph nodes. The rates in
the field, off the field were 0.93%, 1.62% (P =0 . 9 3 7 ) .T h e
5-year cervical lymph node control rate was 96.06%.
Figure 1 Five-year cervical lymph node control.
Figure 2 Five-year local control for T1-2 patients versus T3-4
patients.
Figure 3 Five-year overall survival for T1-2 patients versus T3-4
patients.
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lymph node recurrence rates were 1.14% and 1.08% (p >
0.05) for patients that received radiotherapy to the whole
neck or only the upper neck, respectively. Tang did
research on N0 patients diagnosed by MRI and the results
showed that elective irradiation to the lower neck did not
improve efficacy [16]. These results suggested that elective
node irradiation to the upper neck (II, III, VA) is advisable
for stage N0 patients diagnosed by enhanced CT or MRI
examination of neck.
The reason of discrepancy between different researchers
may be that some clinically diagnosed N0 patients, in fact,
had neck lymph node metastasis. Studies revealed that
20.8- 29.7% clinically N0 patients had cervical lymph node
metastasis by imaging examination. Since CT, MRI and
PET-CT can affect staging, the advanced imaging technol-
ogy is undoubtedly necessary [8]. Imaging studies have
shown that the spread pattern of neck lymph node has a
certain order, rarely skipping in their progression [16,17].
Tang analyzed 786 nasopharyngeal carcinoma diagnosed
by MRI: retropharyngeal lymph node and II lymph node is
the most common metastasis site, followed by III, VA and
IV. And supraclavicular lymph nodes are the third station.
Neck dissection is an effective treatment for residual or
recurrent cervical lymph nodes after radiotherapy [18,19].
Before radiotherapy, enhanced CT of neck was done in
our patients of this group. The 5-year neck recurrence
rate was 5.7%. Recurrence sites in four patients appeared
in II drainage region and one patient failed in IA region
accompanied by nasopharyngeal recurrence. There were
no recurrences in IV region or supraclavicular lymph
nodes. Four patients failed in cervical lymph node only,
but long-term survival was still achieved after neck
dissection.
When patients are diagnosed as nasopharyngeal carci-
noma, almost 75% already have neck lymph node metasta-
sis. The most common cause of death after radiotherapy is
distant metastasis, followed by nasopharyngeal and cervi-
cal recurrence [20-22]. Many studies confirm that lymph
node metastasis is related to distant metastasis [20-22].
However, for N0 patients, nasopharyngeal recurrence is
most common, followed by distant metastasis and regional
recurrence, which is rare [13-15]. Li analyzed 178 N0
patients with nasopharyngeal carcinoma: nasopharyngeal
recurrence appeared in 29, distant metastasis in 20, and
regional recurrence in 2 patients. Chen’sa n a l y s i so f4 3 2
N0 patients showed that the causes of treatment failure
were in order of frequency: nasopharyngeal recurrence,
distant metastasis, and regional recurrence. In our group,
10 patients had nasopharyngeal recurrence, 8 distant
metastasis, and 5 neck recurrence, including 1 patient who
had concurrent nasopharyngeal relapse. Therefore, redu-
cing nasopharyngeal recurrence is of great importance for
improving the efficacy of radiotherapy.
Neck irradiation not only induced neck fibrosis, but
also carotid occlusive diseases including ischemic stroke,
ocular ischemic syndrome [23,24]. Li reported results of
31 patients who underwent carotid duplex sonography
(CDS). Significant carotid lesions occurred in 13 of 31
(42%) patients. Stroke was more frequently caused by
large artery disease (44% versus 23%; p < 0.01) in NPC
patients than in first-ever stroke patients without NPC.
In recent years, many articles have reported that
IMRT technology and concomitant chemoradiotherapy
can improve nasopharyngeal local control rate and
reduce the distant metastasis rate [25-28] and that MRI
has more advantages than CT for the staging system
[29]. However, at the time our patients of this group
were treated, these therapies and technologies were not
yet available. Whether the order of causes of failure
would change should be investigated when these meth-
ods are applied to N0 patients.
In summary, the causes of failure of N0 patients with
nasopharyngeal carcinoma after elective irradiation of
upper neck were in order of frequency nasopharyngeal
recurrence, distant metastasis, and regional recurrence.
Regional recurrence alone is rare and did not affect sig-
nificantly the long-term survival after neck dissection.
Elective irradiation of upper neck (II, III, VA) irradiation
may be advisable for stage N0 patients diagnosed by
enhanced CT examination of neck. A prospective rando-
mized Phase III trial of elective radiation including
whole neck vs upper neck in N0 nasopharyngeal carci-
noma patients is necessary in this new era of IMRT and
MRI.
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